Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation.


Baş V. N. , Ozkan M., Zenciroğlu A., Cavuşoğlu Y., Cetinkaya S., Aycan Z.

Journal of pediatric endocrinology & metabolism : JPEM, vol.25, pp.553-5, 2012 (SCI-Expanded) identifier identifier identifier